| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | KITE PHARMA INCORPORATED | 46,500 | 2,682,000 | 0.11% | ||
| 102 | MYRIAD GENETICS INC | 74,800 | 2,648,000 | 0.10% | Call | |
| 103 | MYRIAD GENETICS INC | 74,800 | 2,648,000 | 0.10% | ||
| 104 | BIODELIVERY SCIENCES INTL IN | 250,000 | 2,625,000 | 0.10% | ||
| 105 | COMMUNITY HEALTH SYS INC NEW | 50,000 | 2,614,000 | 0.10% | Call | |
| 106 | IMMUNOMEDICS INCORPORATED | 500,000 | 1,915,000 | 0.08% | ||
| 107 | ELEVEN BIOTHERAPEUTICS INC | 195,964 | 1,748,000 | 0.07% | ||
| 108 | SORRENTO THERAPEUTICS INC COM NEW | 142,597 | 1,648,000 | 0.07% | ||
| 109 | SAREPTA THERAPEUTICS INC | 115,100 | 1,529,000 | 0.06% | Call | |
| 110 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 1,390,000 | 0.06% | ||
| 111 | CELLECTIS S A | 40,000 | 1,384,000 | 0.05% | ||
| 112 | SAGE THERAPEUTICS INC | 15,000 | 753,000 | 0.03% | ||
| 113 | ZAFGEN INC COM | 13,307 | 527,000 | 0.02% | ||
| 114 | MACROGENICS INC | 12,743 | 400,000 | 0.02% | ||
| 115 | XENCOR INC COM | 20,000 | 306,000 | 0.01% | ||
| 116 | OncoGenex Pharmaceuticals Inc | 113,100 | 243,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-15-034890, filed 2015.05.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
